世界の早産治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04356)
◆英語タイトル:Global Premature Labor Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04356
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:90
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは早産治療の世界市場について調査・分析した資料です。種類別(プロゲステロン、OBE-022、レトシバン、その他)の市場規模、用途別(病院、診療所、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別早産治療の競争状況、市場シェア
・世界の早産治療市場:種類別市場規模 2015年-2020年(プロゲステロン、OBE-022、レトシバン、その他)
・世界の早産治療市場:種類別市場規模予測 2021年-2026年(プロゲステロン、OBE-022、レトシバン、その他)
・世界の早産治療市場:用途別市場規模 2015年-2020年(病院、診療所、その他)
・世界の早産治療市場:用途別市場規模予測 2021年-2026年(病院、診療所、その他)
・北米の早産治療市場分析:米国、カナダ
・ヨーロッパの早産治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの早産治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の早産治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの早産治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AMAG Pharmaceuticals Inc、GlaxoSmithKline Plc、Juniper Pharmaceuticals Inc、Kissei Pharmaceutical Co Ltd、Lipocine Inc、ObsEva SA
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Premature Labor Treatment Market
The global Premature Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Premature Labor Treatment Scope and Market Size
Premature Labor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Premature Labor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AMAG Pharmaceuticals Inc
GlaxoSmithKline Plc
Juniper Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Lipocine Inc
ObsEva SA

Market segment by Type, the product can be split into
Progesterone
OBE-022
Retosiban
Others
Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Premature Labor Treatment Revenue
1.4 Market by Type
1.4.1 Global Premature Labor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Progesterone
1.4.3 OBE-022
1.4.4 Retosiban
1.4.5 Others
1.5 Market by Application
1.5.1 Global Premature Labor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Premature Labor Treatment Market Perspective (2015-2026)
2.2 Global Premature Labor Treatment Growth Trends by Regions
2.2.1 Premature Labor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Premature Labor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Premature Labor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Premature Labor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Premature Labor Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Premature Labor Treatment Players by Market Size
3.1.1 Global Top Premature Labor Treatment Players by Revenue (2015-2020)
3.1.2 Global Premature Labor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Premature Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Premature Labor Treatment Market Concentration Ratio
3.2.1 Global Premature Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Premature Labor Treatment Revenue in 2019
3.3 Premature Labor Treatment Key Players Head office and Area Served
3.4 Key Players Premature Labor Treatment Product Solution and Service
3.5 Date of Enter into Premature Labor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Premature Labor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Premature Labor Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Premature Labor Treatment Market Size by Application (2015-2020)
5.2 Global Premature Labor Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Premature Labor Treatment Market Size (2015-2020)
6.2 Premature Labor Treatment Key Players in North America (2019-2020)
6.3 North America Premature Labor Treatment Market Size by Type (2015-2020)
6.4 North America Premature Labor Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Premature Labor Treatment Market Size (2015-2020)
7.2 Premature Labor Treatment Key Players in Europe (2019-2020)
7.3 Europe Premature Labor Treatment Market Size by Type (2015-2020)
7.4 Europe Premature Labor Treatment Market Size by Application (2015-2020)

8 China
8.1 China Premature Labor Treatment Market Size (2015-2020)
8.2 Premature Labor Treatment Key Players in China (2019-2020)
8.3 China Premature Labor Treatment Market Size by Type (2015-2020)
8.4 China Premature Labor Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Premature Labor Treatment Market Size (2015-2020)
9.2 Premature Labor Treatment Key Players in Japan (2019-2020)
9.3 Japan Premature Labor Treatment Market Size by Type (2015-2020)
9.4 Japan Premature Labor Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Premature Labor Treatment Market Size (2015-2020)
10.2 Premature Labor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Premature Labor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Premature Labor Treatment Market Size by Application (2015-2020)

11 India
11.1 India Premature Labor Treatment Market Size (2015-2020)
11.2 Premature Labor Treatment Key Players in India (2019-2020)
11.3 India Premature Labor Treatment Market Size by Type (2015-2020)
11.4 India Premature Labor Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Premature Labor Treatment Market Size (2015-2020)
12.2 Premature Labor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Premature Labor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Premature Labor Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AMAG Pharmaceuticals Inc
13.1.1 AMAG Pharmaceuticals Inc Company Details
13.1.2 AMAG Pharmaceuticals Inc Business Overview
13.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Introduction
13.1.4 AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020))
13.1.5 AMAG Pharmaceuticals Inc Recent Development
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Details
13.2.2 GlaxoSmithKline Plc Business Overview
13.2.3 GlaxoSmithKline Plc Premature Labor Treatment Introduction
13.2.4 GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2015-2020)
13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Juniper Pharmaceuticals Inc
13.3.1 Juniper Pharmaceuticals Inc Company Details
13.3.2 Juniper Pharmaceuticals Inc Business Overview
13.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Introduction
13.3.4 Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2015-2020)
13.3.5 Juniper Pharmaceuticals Inc Recent Development
13.4 Kissei Pharmaceutical Co Ltd
13.4.1 Kissei Pharmaceutical Co Ltd Company Details
13.4.2 Kissei Pharmaceutical Co Ltd Business Overview
13.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Introduction
13.4.4 Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2015-2020)
13.4.5 Kissei Pharmaceutical Co Ltd Recent Development
13.5 Lipocine Inc
13.5.1 Lipocine Inc Company Details
13.5.2 Lipocine Inc Business Overview
13.5.3 Lipocine Inc Premature Labor Treatment Introduction
13.5.4 Lipocine Inc Revenue in Premature Labor Treatment Business (2015-2020)
13.5.5 Lipocine Inc Recent Development
13.6 ObsEva SA
13.6.1 ObsEva SA Company Details
13.6.2 ObsEva SA Business Overview
13.6.3 ObsEva SA Premature Labor Treatment Introduction
13.6.4 ObsEva SA Revenue in Premature Labor Treatment Business (2015-2020)
13.6.5 ObsEva SA Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

AMAG Pharmaceuticals Inc、GlaxoSmithKline Plc、Juniper Pharmaceuticals Inc、Kissei Pharmaceutical Co Ltd、Lipocine Inc、ObsEva SA

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の早産治療市場2026:インサイト・予測(Global Premature Labor Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。